These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Studies in the etiology and prevention of bladder carcinoma. Schlegel JU, Pipkin GE, Nishimura R, Duke GA. Trans Am Assoc Genitourin Surg; 1968 Jul 21; 60():14-21. PubMed ID: 5746137 [No Abstract] [Full Text] [Related]
7. Bladder cancer. Price JM. Proc Can Cancer Conf; 1966 Jul 21; 6():224-43. PubMed ID: 5339766 [No Abstract] [Full Text] [Related]
9. Urinary excretion of carcinogenic tryptophane metabolites in cancer of bladder. Bapna BC, Singh SM, Nath A. Indian J Med Res; 1969 Mar 21; 57(3):586-8. PubMed ID: 5824015 [No Abstract] [Full Text] [Related]
15. Formal discussion: chemical and physical carcinogens. Nelson N. Cancer Res; 1965 Sep 21; 25(8):1314-6. PubMed ID: 5839723 [No Abstract] [Full Text] [Related]
16. Urinary bladder carcinogenesis with N-substituted aryl compounds: initiation and promotion. Cohen SM. Natl Cancer Inst Monogr; 1981 Dec 21; (58):63-7. PubMed ID: 7341985 [Abstract] [Full Text] [Related]
17. [Tryptophan metabolic disorder--1 of the criteria for forming groups at high risk for spontaneous bladder cancer]. Prianichnikova MB. Urol Nefrol (Mosk); 1984 Dec 21; (4):61-5. PubMed ID: 6236595 [No Abstract] [Full Text] [Related]
18. Tryptophan metabolism in patients with bladder cancer: geographical differences. Brown RR, Price JM, Friedell GH, Burney SW. J Natl Cancer Inst; 1969 Jul 21; 43(1):295-301. PubMed ID: 5796394 [No Abstract] [Full Text] [Related]